- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Dabrafenib is a BRAFV600 mutation inhibitor mainly used to treat malignant tumors such as BRAFV600E/K mutation positive melanoma and non-small ...
The contraindications for dalafenib mesylate capsules involve specific allergic reactions and drug interactions, and medication for special pop...
Selinexor is a selective nuclear output inhibitor primarily used for the treatment of multiple myeloma and diffuse large B-cell lymphoma. Its ...
Common side effects of Selinexor include hematological toxicity, gastrointestinal reactions, and systemic symptoms, which require dosage adju...
Deucravatinib is an oral TYK2 inhibitor used to treat autoimmune diseases such as moderate to severe plaque psoriasis. Its common side effects ...
Deucravatinib requires special attention to infection risk, cardiovascular events, and medication management for special populations. During tr...
Deucravatinib is a novel oral TYK2 inhibitor that exerts immunomodulatory effects by selectively inhibiting the TYK2-JAK signaling pathway. It ...
The contraindications for Deucravatinib include active infections, severe liver dysfunction, etc. Special populations need to adjust their medi...
The contraindications for ribociclib mainly include severe allergic reactions, specific heart diseases, and severe liver injury. For special ...
Ribociclib is a selective CDK4/6 inhibitor, which is mainly used to treat advanced or metastatic breast cancer with hormone receptor positive (...
